What is the breakup of the Chemiluminescence Immunoassay market based on the product type?

 Chemiluminescence Immunoassay Industry Overview

The global chemiluminescence immunoassay market size was valued at USD 7.34 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.9% from 2021 to 2028.

Chemiluminescence immunoassay (CLIA) solutions are widely applied in the detection of chronic diseases, such as infectious disease, autoimmune disease, cardiovascular disease, diabetes, obesity, and cancer. CLIA is also used by various pharmaceutical companies and research institutes for therapeutic drug monitoring. The increasing awareness about the early diagnosis of chronic diseases and the rising drug discovery and development activities by pharmaceutical companies are considered to be the high-impact rendering drivers for the market.

The COVID-19 pandemic has been crucial in shaping the clinical diagnostic industry research into the development of assays and molecular diagnostic research. Urgent need to aid the development of these diagnostic devices to curb the impact and the spread of the virus is the major area of focus for the leading manufacturers. Several CLIA kits have been proven to provide rapid results with sensitivity rates between the ranges of 64% and 97%. Several manufacturers have developed antigen tests based on CLIA technology. For instance, in October 2020, DiaSorin, an Italy-based CLIA manufacturer, received FDA’s EUA for its new LIAISON SARS-CoV-2 IgM test. This test is intended to be run on the LIAISON XL platform based on CLIA technology for the determination of IgM antibodies to SARS-CoV-2. Thus, with the onset of the pandemic, a rise in technologically advanced testing kits has created immense demand for CLIA test kits.

Gather more insights about the market drivers, restrains and growth of the Global Chemiluminescence Immunoassay market

Major players in the market are focused on the development and launch of technologically advanced CLIA solutions. In May 2019, Inova Diagnostics received the 510(k) clearance of its new QUANTA Flash RF IgA and QUANTA Flash Rheumatoid Factor (RF) IgM chemiluminescent assays from the U.S. FDA. Similarly, in August 2018, Mindray Medical International Limited, a China-based medical device manufacturer, launched its new CL900i - a fully automated benchtop chemiluminescence immunoassay. The introduction of such novel solutions is anticipated to support the market growth during the forecast period.

In the field of clinical diagnostics, CLIA technique is widely used in the detection of chronic diseases, such as cancer, infections, cardiovascular diseases, autoimmune diseases, diabetes mellitus, and neurological diseases. These chronic diseases are the leading causes of disability and mortality worldwide. The incidence of these diseases is rising significantly and hence is expected to drive the demand for effective diagnostic methods, such as CLIA. According to the data published by Globocan, in 2018, around 18,078,957 new cases of cancer were diagnosed globally. In addition, according to the data published by the American Diabetes Association, in 2018, around 34.2 million (10.5% of the population) people in the U.S. had diabetes.

CLIA is one of the latest and most advanced immunoassay techniques available in the market. CLIA technique offers several advantages over the other traditional techniques, such as ELISA and RIA. Regardless of the various advantages that it offers, there are several limitations related to the CLIA technique. One such is the high setup cost involved, which is a major drawback of CLIA technique. These costly devices are not easily adopted in emerging economies, such as India, Brazil, and South Africa, which is expected to hinder the market growth in the near future.

Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.

  • UAE Genetic Testing Market - The UAE genetic testing market size was valued at USD 20.36 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 22.2% by 2030. 
  • Molecular Diagnostics Market - The global molecular diagnostics market size was valued at USD 37.04 billion in 2021 and is expected to decline at a compound annual growth rate (CAGR) of -1.6% from 2022 to 2030.

Chemiluminescence Immunoassay Market Segmentation

Grand View Research has segmented the global chemiluminescence immunoassay market on the basis of product, application, end-use, and region:

Chemiluminescence Immunoassay Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Instruments
  • Consumables
  • Software & Services

Chemiluminescence Immunoassay Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Therapeutic Drug Monitoring
  • Oncology
  • Cardiology
  • Endocrinology
  • Infectious Disease
  • Autoimmune Disease
  • Others

Chemiluminescence Immunoassay End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospitals
  • Clinical Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Others

Chemiluminescence Immunoassay Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Key Companies profiled:

Some prominent players in the global Chemiluminescence Immunoassay market include

  • DiaSorin S.p.A.
  • Abbott Laboratories
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Immunodiagnostic Systems
  • Siemens Healthineers
  • Beckman Coulter Inc.
  • Hoffmann-La Roche AG
  • Inova Diagnostics, Inc.
  • Maccura Biotechnology Co., Ltd.
  • Ortho Clinical Diagnostics

Order a free sample PDF of the Chemiluminescence Immunoassay Market Intelligence Study, published by Grand View Research.

Comments

Post a Comment

Popular posts from this blog

Spinal Implants & Devices Market Forecast Analysis by Manufacturer, Types, Applications and Regions 2023 – 2030

  Spinal Implants & Devices Industry Overview The global  Spinal Implants & Devices Market  size is expected to reach USD 19.0 billion by 2030 and is expected to expand at a CAGR of 5.2% in the forecast period, from 2023 to 2030, according to a new report by Grand View Research, Inc. The growing number of vehicular accidents is leading to increasing new cases of spinal cord injuries (SCIs). Other causes of SCIs include falls, violence, acts of violence, sports and recreation injuries, and diseases. Vehicular or road accidents and falls account for the majority of SCI cases. Fall-induced SCI is common among people aged 65 years and above. Acts of violence such as gunshot wounds or knife wounds account for around 12% of SCI cases. Sports activities such as diving in shallow water and impact sports lead to nearly 10% of SCIs. Cancer, osteoporosis, arthritis, and inflammation of the spinal cord also cause SCI. Based on National Spinal Cord Injury Statistical Center data, around 296
Read more

Latin America Pharmaceutical Contract Manufacturing & Research Services Market Overview, Cost Structure Analysis and Forecast to 2030

  Latin America Pharmaceutical Contract Manufacturing & Research Services Industry Overview The  Latin America Pharmaceutical Contract Manufacturing & Research Services Market  size is expected to reach USD 40.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 7.5% from 2022 to 2030. The low cost of drug registration in Latin American countries and the economic growth are the key factors contributing to progress in this region. Moreover, factors such as the growing demand for generics, rising investments in R&D, the growing geriatric population, and the increasing burden of chronic diseases are responsible for market growth. The outbreak of COVID-19 has boosted the market growth as companies have increased investments in R&D and manufacturing to develop vaccines and drugs against the COVID-19. During the coronavirus outburst, the supply chains of biopharmaceutical companies remained robust and were larg
Read more

Coffee Roasters Market Insights, Growth Factors and Forecast Analysis till 2025

Image
01 st November 2018 - Global Coffee Roasters Market is segmented on the basis of energy source, flavor, product type, mode of operation, application and region. Coffee is one of the world’s most popular beverages. Coffee roaster is a machine for coffee roasting. Roasting coffee does transform the physical and chemical properties of green coffee beans into various roasted coffee products. The process of roasting gives typical flavor of coffee by causing green coffee beans to expand and change in taste, color, density, and smell. Raw beans do contain similar protein, acids, and caffeine as those that have been roasted, but lag behind as far as taste is concerned. Request a Sample Copy of Coffee Roasters Market Report @ https://www.millioninsights.com/industry-reports/coffee-roasters-market/request-sample Majority of coffee is roasted commercially on a large scale, but some coffee drinkers roast coffee at home for exercising more control over the flavor and freshness profil
Read more